OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 54 filers reported holding OYSTER PT PHARMA INC in Q4 2022. The put-call ratio across all filers is 4.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $30,925,106 | +98.8% | 2,768,586 | 0.0% | 16.46% | +92.7% |
| Q3 2022 | $15,559,000 | +29.8% | 2,768,586 | 0.0% | 8.54% | +18.0% |
| Q2 2022 | $11,988,000 | -62.8% | 2,768,586 | 0.0% | 7.24% | -49.5% |
| Q1 2022 | $32,226,000 | -36.3% | 2,768,586 | 0.0% | 14.34% | -6.7% |
| Q4 2021 | $50,554,000 | +54.1% | 2,768,586 | 0.0% | 15.36% | +74.8% |
| Q3 2021 | $32,808,000 | -31.1% | 2,768,586 | 0.0% | 8.79% | -7.3% |
| Q2 2021 | $47,592,000 | -6.0% | 2,768,586 | 0.0% | 9.48% | -18.2% |
| Q1 2021 | $50,610,000 | -2.9% | 2,768,586 | 0.0% | 11.60% | -46.7% |
| Q4 2020 | $52,105,000 | -10.8% | 2,768,586 | 0.0% | 21.78% | -22.5% |
| Q3 2020 | $58,445,000 | -26.9% | 2,768,586 | 0.0% | 28.12% | -2.7% |
| Q2 2020 | $79,957,000 | -11.8% | 2,768,586 | +6.9% | 28.90% | -35.1% |
| Q1 2020 | $90,651,000 | +43.2% | 2,590,015 | 0.0% | 44.50% | +38.6% |
| Q4 2019 | $63,300,000 | – | 2,590,015 | – | 32.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |